Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72
Choosing the proper needle size is essential when you inject semaglutide, a medication administered via subcutaneous injections for conditions like type 2 diabetes and weight loss
It works through several mechanisms: it slows gastric emptying (so food stays in your stomach longer and you feel full sooner), it reduces appetite signals in the brain, and it improves insulin sensitivity
This test is not a pharmacogenomic test of antidepressant metabolism
Addressing the Thyroid C-Cell Hyperplasia Concern People often ask if they can take GLP-1 with hypothyroidism, given concerns about thyroid health
Avoid this by not eating right before going to bed